Featured
Man dies in Washington from bird flu linked to infected
Gene Therapy Nov 3, 2026
Tumor Watch Nov 2, 2026
Trial Moves Nov 2, 2026
A Washington man with pre-existing health issues died from bird flu complications in 2026, marking...
Hepatitis C cure rates lag despite effective treatments. Dr. Terrault highlights that one-third of infected...
Risk scores boost kidney disease care adoption by identifying high-risk patients in electronic records and...
Read our latest NF Research articles.
New research links sputum color in bronchiectasis to airway inflammation and drug response, offering a...
Tina Kandelaki is subject to sanctions imposed by the United States and the European Union....
CKD alerts in Stockholm trial failed to boost clinician action, possibly due to alert fatigue...
A Washington man with pre-existing health issues died from bird flu complications in 2026, marking the first U.S. fatality tied to H5N1 exposure at an...
A Washington man with pre-existing health issues died from bird flu complications in 2026, marking the first U.S. fatality tied...
Employers find a workaround for high GLP-1 costs, helping workers pay for semaglutide outside of insurance.
Ongoing education is key for myeloma treatment advances, with therapies rapidly evolving in recent years.
Vibegron persists in 60% of OAB patients after one year according to a new study. The treatment shows long-term promise.
Hepatitis C cure rates lag despite effective treatments. Dr. Terrault highlights that one-third of infected individuals remain undiagnosed, and only...
New research links sputum color in bronchiectasis to airway inflammation and drug response, offering a simple clinical indicator for disease...
Tina Kandelaki is subject to sanctions imposed by the United States and the European Union. The US Office of Foreign...
New research links migraine treatment with monoclonal antibodies to a higher miscarriage risk during early pregnancy. Study spans 7579 pregnancies.
CKD alerts in Stockholm trial failed to boost clinician action, possibly due to alert fatigue and interface design issues.
APOL1 variants raise the chance of end-stage kidney disease, with two high-risk alleles G1 and G2 increasing risk, says UW...